
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. (SPRY)
WebsitePrice
Market cap
Next catalystExpected Q1 2027ARS-2 — outpatient Phase 2b CSU trial · Phase 2 dataSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
Approved / commercial
PreINDP1P2P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved